Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- Engagement with the patient decision aid
研究概览
简要总结
The aim of this study is to learn whether participants find a patient guide to breast cancer treatment decisions acceptable and appropriate for use.
详细描述
This study seeks to adapt and pilot test de-implementation strategies targeting low-value breast cancer treatments which have persisted despite national recommendations. Breast cancer is an ideal setting in which to study de-implementation given it is common, well-studied, typically presents at an early-stage, and care is provided primarily in a community setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 70 Years 至 —（Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Early stage breast cancer that is hormone receptor positive (HR+) and human epidermal growth factor negative (HER2-)
- •Meet criteria for omission of sentinel lymph node biopsy (SLNB)
- •Receiving care at Michigan Medicine
排除标准
- •Non-English speaking
- •Male patients (current data does not support omission of SLNB in men)
研究组 & 干预措施
Breast cancer decision aid
Participants receive a breast cancer decision aid.
干预措施: Breast cancer decision aid (Behavioral)
结局指标
主要结局
Engagement with the patient decision aid
时间窗: 1 week after receiving decision aid
To determine feasibility, participants will be asked whether they engaged with the patient decision aid (1=thoroughly, 2=somewhat or 3=not at all), scored as a mean. The median score across all participants will be reported.
Acceptability of Intervention (AIM) Survey
时间窗: 1 week after receiving decision aid
AIM is a validated, 4-item survey with all items measured on a 5-point Likert scale (Completely Disagree \[1\] - Completely Agree \[5\]), scored as a mean. The median score across all participants will be reported.
Intervention Appropriateness Measure (IAM)
时间窗: 1 week after receiving decision aid
IAM is a validated, 4-item survey with all items measured on a 5-point Likert scale (Completely Disagree \[1\] - Completely Agree \[5\]), scored as a mean. The median score across all participants will be reported.
次要结局
- Satisfaction with decision (SWD)(up to 120-days following surgery)
- Treatment choice(90 days after surgery)